Stay updated on Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial

Sign up to get notified when there's something new on the Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent change in the webpage content.
    Difference
    0.1%
    Check dated 2024-06-13T22:43:16.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update or modification in the context of Medical and healthcare-related publications and documentation.
    Difference
    0.1%
    Check dated 2024-06-06T14:33:44.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying that only patients with APC nonsense stop codon mutations, who are above 18 years old and lack known sensitivity to erythromycin or other macrolides, are eligible. The criteria also detail specific conditions regarding the size and classification of polyps and tumors for inclusion and exclusion.
    Difference
    16%
    Check dated 2024-05-22T20:55:53.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:51:13.000Z thumbnail image

Stay in the know with updates to Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial page.